RENN FUND INC (RCG)

US7597201059

1.6099  +0.01 (+0.62%)

Fundamental Rating

3

Taking everything into account, RCG scores 3 out of 10 in our fundamental rating. RCG was compared to 212 industry peers in the Capital Markets industry. The financial health of RCG is average, but there are quite some concerns on its profitability. While showing a medium growth rate, RCG is valued expensive at the moment.



1

1. Profitability

1.1 Basic Checks

In the past year RCG has reported negative net income.
The reported net income has been mixed in the past 5 years: RCG reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: RCG reported negative operating cash flow in multiple years.

1.2 Ratios

RCG has a Return On Assets of -6.34%. This is amonst the worse of the industry: RCG underperforms 93.81% of its industry peers.
Looking at the Return On Equity, with a value of -6.39%, RCG is doing worse than 82.86% of the companies in the same industry.
RCG has a Return On Invested Capital of 0.06%. This is amonst the worse of the industry: RCG underperforms 82.38% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -6.39%
ROIC 0.06%
ROA(3y)-1.31%
ROA(5y)0.86%
ROE(3y)-1.33%
ROE(5y)1.1%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

RCG's Operating Margin of 3.50% is on the low side compared to the rest of the industry. RCG is outperformed by 81.90% of its industry peers.
With a decent Gross Margin value of 73.94%, RCG is doing good in the industry, outperforming 75.24% of the companies in the same industry.
Industry RankSector Rank
OM 3.5%
PM (TTM) N/A
GM 73.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

5

2. Health

2.1 Basic Checks

The number of shares outstanding for RCG remains at a similar level compared to 1 year ago.
The number of shares outstanding for RCG has been increased compared to 5 years ago.
RCG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 56.21 indicates that RCG is not in any danger for bankruptcy at the moment.
RCG has a better Altman-Z score (56.21) than 99.52% of its industry peers.
RCG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 56.21
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.77 indicates that RCG may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.77, RCG is doing worse than 66.67% of the companies in the same industry.
A Quick Ratio of 0.77 indicates that RCG may have some problems paying its short term obligations.
RCG's Quick ratio of 0.77 is on the low side compared to the rest of the industry. RCG is outperformed by 66.19% of its industry peers.
Industry RankSector Rank
Current Ratio 0.77
Quick Ratio 0.77

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.10% over the past year.
The Revenue has grown by 27.92% in the past year. This is a very strong growth!
RCG shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 35.03% yearly.
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-29394.74%
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y35.03%
Revenue growth Q2Q26.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RCG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.94%, RCG is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 7.04, RCG is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.32, RCG's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.94%

5.2 History

RCG has paid a dividend for at least 10 years, which is a reliable track record.
The dividend of RCG decreased recently.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

DP0%
EPS Next 2YN/A
EPS Next 3YN/A

RENN FUND INC

NYSEARCA:RCG (5/17/2024, 7:22:52 PM)

1.6099

+0.01 (+0.62%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap11.30M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 0.94%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -6.39%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.5%
PM (TTM) N/A
GM 73.94%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.77
Quick Ratio 0.77
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)79.1%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)27.92%
Revenue growth 3Y57.96%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y